Development and Characterization of Itraconazole-loaded Solid Lipid Nanoparticles for Ocular Delivery
Overview
Pharmacy
Affiliations
The purpose of this study was to investigate the feasibility of entrapping water-insoluble drug itraconazole into solid lipid nanoparticles (SLNs) for topical ocular delivery. The drug-loaded SLNs were prepared from stearic acid and palmitic acid using different concentrations of polyvinyl alcohol employed as emulsifier. SLNs were prepared by the melt-emulsion sonication and low temperature-solidification method and characterized for particle size, zeta potential, drug loading and drug entrapment efficiency. The mean particle size of SLNs prepared with stearic acid ranged from 139 to 199 nm, while the SLNs prepared with palmitic acid had particle size in the range of 126-160 nm. The SLNs were spherical in shape. Stearic acid-SLNs showed higher entrapment of drug compared with palmitic acid-SLNs. Differential scanning calorimetry (DSC) and X-ray diffraction measurements showed decrease in crystallinity of drug in the SLN formulations. The modified Franz-diffusion cell and freshly excised goat corneas were used to test drug corneal permeability. Permeation of itraconazole from stearic acid-SLNs was higher than that obtained with palmitic acid-SLNs. The SLNs showed clear zone of inhibition against Aspergillus flavus indicating antimicrobial efficacy of formulations.
Fouad S, Badr T, Abdelbary A, Fadel M, Abdelmonem R, Jasti B AAPS PharmSciTech. 2024; 25(7):237.
PMID: 39384727 DOI: 10.1208/s12249-024-02943-2.
Tan X, Wang C, Zhou H, Zhang S, Liu X, Yang X J Nanobiotechnology. 2023; 21(1):183.
PMID: 37291573 PMC: 10249277. DOI: 10.1186/s12951-023-01950-y.
Solid lipid nanoparticles, an effective carrier for classical antifungal drugs.
Almawash S Saudi Pharm J. 2023; 31(7):1167-1180.
PMID: 37273269 PMC: 10236373. DOI: 10.1016/j.jsps.2023.05.011.
Bhattacharya S, Sharma S, Prajapati B Front Oncol. 2022; 12:990841.
PMID: 36387097 PMC: 9644033. DOI: 10.3389/fonc.2022.990841.
Lipid Nanoparticles for the Posterior Eye Segment.
Bonilla L, Espina M, Severino P, Cano A, Ettcheto M, Camins A Pharmaceutics. 2022; 14(1).
PMID: 35056986 PMC: 8779178. DOI: 10.3390/pharmaceutics14010090.